r IOL implantation during cataract surgery; and the LuxOR LX3 surgical microscope for greater visualization during surgery. The portfolio also includes Contoura vision, the vision system in the wavelight refractive suite portfolio for refractive procedures and LASIK treatments; the Constellation vision system for retinal operations; and the Infiniti vision system to perform cataract surgeries, which is the phacoemulsification platform. The company also offers the AcrySof family of IOLs to treat cataracts, including the AcrySof IQ, AcrySof IQ PanOptix, AcrySof IQ Toric, and AcrySof IQ ReSTOR Toric IOLs. In addition, it provides advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery. Ophthalmic Pharmaceuticals This division's Ophthalmic Pharmaceuticals franchise develops and markets a range of pharmaceuticals to treat chronic and acute conditions of the eye, including glaucoma, elevated intraocular pressure (associated with glaucoma), eye infection and inflammation, eye allergies, dry eye, and retinal diseases. Ophthalmic Pharmaceuticals also oversees the line of professionally driven over-the-counter brands that include artificial tears and ocular vitamins. The company’s portfolio includes Ilevro ophthalmic suspension for the treatment of pain and inflammation associated with cataract surgery; Simbrinza suspension to lower intraocular pressure as a fixed-dose combination; Azopt, Azarga, Travatan Z, and DuoTrav, each ophthalmic solutions for the treatment of elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension; Vigamox ophthalmic solution for bacterial conjunctivitis; Pazeo and Pataday ophthalmic solutions for ocular itching associated with allergic conjunctivitis; Nevanac ophthalmic suspension for eye pain and inflammation following cataract surgery and to reduce the risk of macular edema associated with cataract surgery in diabetic patients; the Systane family of over-the-counter products for dry eye relief; and Jetrea intravitreal injection for treating vitreomacular traction. Vision Care The company’s Alcon division's Vision Care franchise develops and markets contact lenses and lens care products. The company’s portfolio of silicone hydrogel, daily disposables, and color contact lenses includes its Air Optix, Dailies, and Freshlook brands. Its Dailies product line includes Dailies Total1 lenses, a water gradient contact lens. The company’s Air Optix monthly contact lens product line includes Air Optix Colors silicone hydrogel contact lenses. Its contact lens care solutions business includes the Opti-Free line of multi-purpose disinfecting solutions and drops, as well as the Clear Care and AOSept Plus hydrogen peroxide lens care solutions. Sales and Marketing The company’s Alcon division conducts sales and marketing activities around the world organized under five operating regions (the U.S., Europe/the Middle East/Africa, Latin America/the Caribbean/Canada, Asia, and Japan). Research and Development In 2015, the company’s Alcon division expensed $0.9 billion in research and development. Sandoz The company’s Sandoz division offers generic pharmaceuticals and biosimilars. It sells products in approximately 160 countries. The Sandoz division is organized globally in three franchises, such as Retail Generics, Anti-Infectives, and Biopharmaceuticals and Oncology Injectables. In Retail Generics, Sandoz division develops, manufactures, and markets active ingredients and finished dosage forms of pharmaceuticals to third parties. Retail Generics includes the areas of dermatology, respiratory, and ophthalmics, as well as cardiovascular, metabolism, central nervous system, pain, gastrointestinal, and hormonal therapies. Finished dosage form anti-infectives sold to third parties are also a part of Retail Generics. In Anti-Infectives, Sandoz division manufactures active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz division develops, manufactures, and ma
novartis ag-sponsored adr (NVS:New York)
Phone: 41 61 324 11 11
Fax: 41 61 324 80 01www.novartis.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for NVS.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact NOVARTIS AG-SPONSORED ADR, please visit www.novartis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.